EFPEGLENATIDE
UNII 3M1V5Z2270

Substance Identification & Data

This profile provides standardized clinical and technical data for Efpeglenatide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3M1V5Z2270.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1296200-77-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3M1V5Z2270

CAS Registry Number

1296200-77-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EFPEGLENATIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166682

National Cancer Institute reference terminology for clinical and research data.

INN ID

9580

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-196

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Efpeglenatide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFPEGLENATIDE

Common Names & Synonyms

EFPEGLENATIDE [INN]

EFPEGLENATIDE [USAN]

EFPEGLENATIDE [WHO-DD]

IMIDAZOACETYL-EXENDIN-4-PEG-IMMUNOGLOBULIN FC FRAGMENT CONJUGATE

LANGLENATIDE

POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-HYDRO-.OMEGA.-HYDROXY-, 26-ETHER WITH N-(2-(1H-IMIDAZOL-5-YL)ACETYL)GLYCYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-LEUCYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-GLUTAMYL-L-ALANYL-L-VALYL-L-ARGINYL-L-LEUCYL-L-PHENYLALANYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-L-TRYPTOPHYL-L-LEUCYL-N6-(3-HYDROXYPROPYL)-L-LYSYL-L-ASPARAGINYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERINAMIDE, 1'-ETHER WITH IMMUNOGLOBULIN G4 (1-(1-(3-HYDROXYPROPYL)PROLINE)) (HUMAN FRAGMENT), (3'->3'')-DISULFIDE WITH IMMUNOGLOBULIN G4 (HUMAN FRAGMENT)

Systematic Nomenclature

EXENATIDE DERIVATIVE AND HUMAN IGG4 FC DIMER LINKED TOGETHER WITH POLYETHYLENE GLYCOL DERIVATIVE: N 6.27 , N . 1'-(.OMEGA.-(OXYPROPANE-1,3-DIYL)-.ALPHA.-(PROPANE-1,3-DIYL)POLY(OXYETHYLENE)) (1-(IMIDAZOL-4-YLACETIC ACID))EXENDIN-4 HELODERMA SUSPECTUM (GILA MONSTER), HUMAN IMMUNOGLOBULIN G4 FC FRAGMENT-(9'-229')-PEPTIDE DIMER (3'-3'')-DISULFIDE

SYS